187 related articles for article (PubMed ID: 22156842)
1. Systems biology in the development of HIV vaccines.
Haddad EK; Pantaleo G
Curr Opin HIV AIDS; 2012 Jan; 7(1):44-9. PubMed ID: 22156842
[TBL] [Abstract][Full Text] [Related]
2. Overcoming limitations in the systems vaccinology approach: a pathway for accelerated HIV vaccine development.
Zak DE; Aderem A
Curr Opin HIV AIDS; 2012 Jan; 7(1):58-63. PubMed ID: 22156843
[TBL] [Abstract][Full Text] [Related]
3. Profiling immunity to HIV vaccines with systems biology.
Andersen-Nissen E; Heit A; McElrath MJ
Curr Opin HIV AIDS; 2012 Jan; 7(1):32-7. PubMed ID: 22134340
[TBL] [Abstract][Full Text] [Related]
4. Human immunodeficiency virus (HIV) immunopathogenesis and vaccine development: a review.
Girard MP; Osmanov S; Assossou OM; Kieny MP
Vaccine; 2011 Aug; 29(37):6191-218. PubMed ID: 21718747
[TBL] [Abstract][Full Text] [Related]
5. Clinical studies of experimental vaccines.
Bart PA; Harari A; Pantaleo G
Curr Opin HIV AIDS; 2006 Jul; 1(4):286-93. PubMed ID: 19372823
[TBL] [Abstract][Full Text] [Related]
6. Systems vaccinology: its promise and challenge for HIV vaccine development.
Nakaya HI; Pulendran B
Curr Opin HIV AIDS; 2012 Jan; 7(1):24-31. PubMed ID: 22156839
[TBL] [Abstract][Full Text] [Related]
7. Current world literature.
Curr Opin HIV AIDS; 2012 Jan; 7(1):86-95. PubMed ID: 22156801
[No Abstract] [Full Text] [Related]
8. Evaluation of yellow fever virus 17D strain as a new vector for HIV-1 vaccine development.
Franco D; Li W; Qing F; Stoyanov CT; Moran T; Rice CM; Ho DD
Vaccine; 2010 Aug; 28(35):5676-85. PubMed ID: 20600494
[TBL] [Abstract][Full Text] [Related]
9. Systems biology in understanding HIV pathogenesis and guiding vaccine development.
Sekaly R; Pulendran B
Curr Opin HIV AIDS; 2012 Jan; 7(1):1-3. PubMed ID: 22134343
[No Abstract] [Full Text] [Related]
10. The role of nonhuman primates in the development of an AIDS vaccine.
Nathanson N; Hirsch VM; Mathieson BJ
AIDS; 1999; 13 Suppl A():S113-20. PubMed ID: 10885770
[TBL] [Abstract][Full Text] [Related]
11. HIV vaccine development at the turn of the 21st century.
Girard MP; Plotkin SA
Curr Opin HIV AIDS; 2012 Jan; 7(1):4-9. PubMed ID: 22156840
[TBL] [Abstract][Full Text] [Related]
12. Poxvirus vector-based HIV vaccines.
Pantaleo G; Esteban M; Jacobs B; Tartaglia J
Curr Opin HIV AIDS; 2010 Sep; 5(5):391-6. PubMed ID: 20978379
[TBL] [Abstract][Full Text] [Related]
13. A systems approach to understanding vaccines.
von Bubnoff A
IAVI Rep; 2010; 14(4):16-20. PubMed ID: 20857649
[TBL] [Abstract][Full Text] [Related]
14. A review of vaccine research and development: the human immunodeficiency virus (HIV).
Girard MP; Osmanov SK; Kieny MP
Vaccine; 2006 May; 24(19):4062-81. PubMed ID: 16530298
[TBL] [Abstract][Full Text] [Related]
15. Correlates of immune protection in HIV-1 infection: what we know, what we don't know, what we should know.
Pantaleo G; Koup RA
Nat Med; 2004 Aug; 10(8):806-10. PubMed ID: 15286782
[TBL] [Abstract][Full Text] [Related]
16. HIV vaccine development: a subtype E-specific strategy.
Brown AE; McNeil JG
Southeast Asian J Trop Med Public Health; 1998 Jun; 29(2):377-82. PubMed ID: 9886132
[TBL] [Abstract][Full Text] [Related]
17. Predictive value of primate models for AIDS.
Haigwood NL
AIDS Rev; 2004; 6(4):187-98. PubMed ID: 15700617
[TBL] [Abstract][Full Text] [Related]
18. Lessons for AIDS vaccine development from non-AIDS vaccines.
Clements-Mann ML
AIDS Res Hum Retroviruses; 1998 Oct; 14 Suppl 3():S197-203. PubMed ID: 9814944
[TBL] [Abstract][Full Text] [Related]
19. HIV vaccine development and evaluation: realistic expectations.
Heyward WL; MacQueen KM; Goldenthal KL
AIDS Res Hum Retroviruses; 1998 Oct; 14 Suppl 3():S205-10. PubMed ID: 9814945
[TBL] [Abstract][Full Text] [Related]
20. [Vaccines against HIV].
Holm-Hansen C
Tidsskr Nor Laegeforen; 2006 Nov; 126(23):3117-20. PubMed ID: 17160118
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
